NDC 0135-0574 – Gaviscon
Aluminum Hydroxide 254 mg/5mL; Magnesium Carbonate 237.5 mg/5mL · Liquid · Oral
Product NDC0135-0574
Product details
- Brand name
- Gaviscon
- Generic name
- Aluminum hydroxide and magnesium carbonate
- Labeler
- Haleon US Holdings LLC
- Dosage form
- Liquid
- Route
- Oral
- Marketing category
- OTC MONOGRAPH DRUG · M001
- Marketed since
- August 1, 2014
- Listing expires
- December 31, 2027
Active ingredients
- Aluminum Hydroxide 254 mg/5mL
- Magnesium Carbonate 237.5 mg/5mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0135-0574-01 | 355 mL in 1 BOTTLE (0135-0574-01) | Aug 1, 2014 |
Recalls mentioning this NDC
- D-1324-2020 Jun 24, 2020 · Class II
Labeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label. - D-1322-2020 Jun 24, 2020 · Class II
Labeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label. - D-1323-2020 Jun 24, 2020 · Class II
Labeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label. - D-1325-2020 Jun 24, 2020 · Class II
Labeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.
Other Gaviscon products
- 0135-0094 Aluminum Hydroxide 95 mg/15mL; Magnesium Carbonate 358 mg/15mL · Liquid · Haleon US Holdings LLC
- 0135-0095 Aluminum Hydroxide 254 mg/5mL; Magnesium Carbonate 237.5 mg/5mL · Liquid · Haleon US Holdings LLC
- 0135-0098 Aluminum Hydroxide 160 mg/1; Magnesium Carbonate 105 mg/1 · Tablet, Chewable · Haleon US Holdings LLC
- 0135-0430 Aluminum Hydroxide 160 mg/1; Magnesium Carbonate 105 mg/1 · Tablet, Chewable · Haleon US Holdings LLC